David Matthew Shaw

This inventor holds 25 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Sodium Channel Modulators. Top assignees: Vertex Pharmaceuticals, Inc., Other. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Matthew Shaw. Retrieved from https://idiyas.com/inventor/david-matthew-shaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 9)

% Patents Active = 92.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 11.7

ph-index = 6

Forward Citations = 198(Granted Patents)

Location History:

Halesowen, West Midlands B63 3TG, GB (1992)
Abingdon, GB (2014)
Oxford, GB (2015 - 2024)

Company Filing History:

24 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

1 out of 834,570

Other

patents

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

Sodium Channels

ATR Kinase Inhibitors

Tetrahydrofurans

Carboxamides

Esters

Cyclic Compounds

Modulators

Pharmaceuticals

Heterocycles

Inhibitors

Compounds

Drug Development

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662470 - Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channels (2026-06-23),

2. 12441703 - Carboxamides as modulators of sodium channels (2025-10-14),

3. 12440481 - Esters and carbamates as modulators of sodium channels (2025-10-14),

4. 12281057 - Carboxamides as modulators of sodium channels (2025-04-21),

5. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels (2025-03-25),

6. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels (2025-03-11),

7. 12187731 - Compounds useful as inhibitors of ATR kinase (2025-01-07),

8. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels (2024-03-05),

9. 11834441 - Substituted tetrahydrofurans as modulators of sodium channels (2023-12-05),

10. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels (2023-11-28),

11. 11603351 - Carboxamides as modulators of sodium channels (2023-03-14),

12. 11485739 - Compounds useful as inhibitors of ATR kinase (2022-11-01),

13. 11370798 - Compounds useful as inhibitors of ATR kinase (2022-06-28),

14. 11117900 - Compounds useful as inhibitors of ATR kinase (2021-09-14),

15. 10815239 - Compounds useful as inhibitors of ATR kinase (2020-10-27),

Title: The Inventor David Matthew Shaw

Introduction: David Matthew Shaw, a talented inventor hailing from Abingdon, GB, has made significant contributions to the field of innovation with his creative and groundbreaking ideas.

Latest Patents: David Matthew Shaw holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his career, David Matthew Shaw has been recognized for his exceptional problem-solving skills and ability to turn ideas into practical solutions. His work has revolutionized multiple sectors, leaving a lasting impact on the industry.

Collaborations: David Matthew Shaw has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in the successful development and commercialization of his innovative concepts.

Conclusion: In conclusion, David Matthew Shaw stands out as a visionary inventor who continues to push the boundaries of innovation. His passion for creating solutions to complex problems sets him apart in the world of inventors.

Profile summary based on public USPTO records.